Cambridge, UK, 10 January 2012: Horizon Discovery (Horizon), a leading provider of research tools to support the development of personalized medicines, has announced the appointment of Simon Cook as a non-executive director.
Simon is currently CEO of DFJ Esprit. He has been involved with a number of successful technology start-ups, and has been associated with European Venture Capital since 1995. Past board roles include Lovefilm (Amazon), Cambridge Silicon Radio (IPO LSE), Virata (IPO Nasdaq), nCipher (IPO LSE) and KVS (Symantec). Simon is a graduate of University of Manchester Institute of Science and Technology (UMIST).
Commenting on the announcement, Dr Darrin M Disley, CEO of Horizon said: “On behalf of Horizon and the board of directors, I would like to welcome Simon to Horizon. His expertise will be a valuable addition to the company as we continue to build a world-leading translational genomics company.”
Simon commented: “Horizon is a leading light in UK biotech. I’m delighted to join the board of directors at this pivotal time in the company’s development.”
Horizon’s mission is to provide its customers with cutting-edge biological tools and services that will accelerate the pace of development of ‘stratified’ or ‘personalized’ medicines. Last year the Company grew from 25 to more than 65 FTEs.